FDA Inspection 1098819 — Supernus Pharmaceuticals, Inc.
The FDA completed an inspection of Supernus Pharmaceuticals, Inc. on Jul 10, 2019 in Rockville, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 10, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Rockville, MD (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)